跳至主要内容
临床试验/NCT03997500
NCT03997500已完成不适用

Prophylactic Norepinephrine Infusion for Spinal Hypotension and Inferior Vena Cava Collapsibility Index During Cesarean Delivery: a Randomized Double Blinded Controlled Study

General Hospital of Ningxia Medical University1 个研究点 分布在 1 个国家目标入组 195 人开始时间: 2019年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
195
试验地点
1
主要终点
The incidence of hypotension

研究概览

简要总结

The purpose of this study is to investigate the preventive effect of norepinephrine on post-spinal hypotension and the effect of norepinephrine on inferior vena cava collapsibility index (IVC-CI).

详细描述

Post-spinal hypotension is a frequent complication during spinal anesthesia for cesarean delivery. It affects nearly 50-60% of patients without appropriately treat. Vasopressors has been highly recommended for routine prevention and/or treatment of post-spinal hypotension. Norepinephrine is new vasopressor that has been suggested as a potential alternative to phenylephrine and was recently introduced in obstetric anesthesia because of the minimal cardiac depressant effect. The purpose of this study is to investigate the preventive effect of norepinephrine on post-spinal hypotension and the effect on inferior vena cava collapsibility index (IVC-CI).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • 18-45 years
  • American Society of Anesthesiologists physical status classification I to II
  • Scheduled for elective cesarean delivery under spinal anesthesia
  • Full-term, singleton, pregnant women

排除标准

  • Height of no more than 150 centimeters
  • Body weight greater than 100 kg or BMI greater than 30
  • Labor analgesia had been performed
  • Contraindication of spinal or epidural anesthesia
  • Eclampsia or chronic hypertension or baseline blood pressure ≥160mmHg
  • Hemoglobin <7g/dl
  • Fetal distress or known abnormal fetal development
  • Severe vascular disease
  • Diabetes mellitus or cardiovascular disease or nervous system disease

研究组 & 干预措施

Norepinephrine

Experimental

Simultaneous with subarachnoid block, a bolus of norepinephrine was given followed by norepinephrine infusion

干预措施: Norepinephrine (Drug)

Normal saline

Placebo Comparator

Simultaneous with subarachnoid block, a bolus of normal saline was given followed by normal saline infusion

干预措施: normal saline (Drug)

结局指标

主要结局

The incidence of hypotension

时间窗: 1 to 20 minutes after subarachnoid block

SBP decreased to \<80% of the baseline value

Inferior vena cava collapsibility index

时间窗: 5 to 20 minutes after subarachnoid block

CI = (dIVCmax - dIVCmin)/dIVCmax

次要结局

  • Arterial base excess of fetal vein blood(Immediately after delivery)
  • Incidence of hypertension(1 to 20 minutes after subarachnoid block)
  • Number of rescue norepinephrine(Immediately to 20 minutes after subarachnoid block)
  • APGAR score(10min after delivery)
  • The incidence of nausea and vomiting(1 to 20 minutes after subarachnoid block)
  • The incidence of bradycardia(1 to 20 minutes after subarachnoid block)
  • Pressure of oxygen of fetal vein blood(Immediately after delivery)
  • pH value of fetal vein blood(Immediately after delivery)

研究者

发起方
General Hospital of Ningxia Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验